BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 10179319)

  • 1. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(80 Pt 1):20558-61. PubMed ID: 10179320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical devices; reports of corrections and removals--FDA. Direct final rule.
    Fed Regist; 1998 Aug; 63(152):42229-33. PubMed ID: 10181725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices; establishment registration and device listing for manufacturers and distributors of devices--FDA. Direct final rule.
    Fed Regist; 1998 Sep; 63(188):51825-7. PubMed ID: 10185812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Final rule.
    Fed Regist; 1998 Oct; 63(195):54042-4. PubMed ID: 10185825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; humanitarian use of devices--FDA. Direct final rule.
    Fed Regist; 1998 Apr; 63(74):19185-90. PubMed ID: 10178430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
    Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical devices; reports of corrections and removals; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Aug; 63(152):42300-4. PubMed ID: 10181727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical devices; medical device reporting; baseline reports. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical devices; establishment registration and device listing for manufacturers and distributors of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(188):51874-5. PubMed ID: 10185813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of regulations regarding certification of drugs composed wholly or partly of insulin--FDA. Direct final rule.
    Fed Regist; 1998 May; 63(92):26694-9. PubMed ID: 10179341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisions to the general safety requirements for biological products--FD. Direct final rule.
    Fed Regist; 1998 Apr; 63(75):19399-403. PubMed ID: 10178869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical devices; reprocessed single-use devices; requirement for submission of validation data. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Sep; 71(185):55729-37. PubMed ID: 17017469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical devices; humanitarian use of devices; companion to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Apr; 63(74):19196-200. PubMed ID: 10178431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical devices; pediatric uses of devices; requirement for submission of information on pediatric subpopulations that suffer from a disease or condition that a device is intended to treat, diagnose, or cure; direct final rule. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2010 Apr; 75(62):16347-51. PubMed ID: 20383921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; medical device reporting. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amendment of various device regulations to reflect current American Society for Testing and Material citations. Food and Drug Administration, HHS. Direct final rule.
    Fed Regist; 2000 Jan; 65(15):3584-5. PubMed ID: 11010654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational new drug applications; clinical holds--FDA. Direct final rule.
    Fed Regist; 1998 Dec; 63(239):68676-8. PubMed ID: 10187558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(71):19650-8. PubMed ID: 11010632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.